Omega XL Reports New Independent Study: Intake of Omega-3s Reduces NSAID Consumption In RA Patients

Rheumatoid arthritis patients taking omega-3, such as found in Omega XL, reduced non-steroidal anti-inflammatory drug (NSAID) consumption by 48 percent.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The researchers concluded, "…that the use of omega-3 PUFAs for >3 months reduces NSAID consumption by RA patients."

Fort Lauderdale, FL (PRWEB) August 21, 2012

A recent study conducted at the University College of Medicine in Seoul, Korea, published online in the journal Archives of Medical Research,showed that rheumatoid arthritis patients taking omega-3 polyunsaturated fatty acids (PUFAS), such as found in Omega XL, for a minimum of three months reduced non-steroidal anti-inflammatory drug (NSAID) consumption by 48 percent.

The study compared 183 patients with rheumatoid arthritis treated with omega-3 PUFAS per day and 187 patients treated with a placebo as controls that were enrolled in ten randomized controlled trials.

At the study’s conclusion, the researchers noted that in addition to reducing the use of NSAID, using Omega-3 PUFAS improved several subjective measures of joint pain including tender point count, swollen joint count, morning stiffness and physical function.

The researchers concluded, "…that the use of omega-3 PUFAs for >3 months reduces NSAID consumption by RA patients."

Omega XL is one of only two Omega-3 supplements sold in the world that contains the patented stabilized marine lipid extract PCSO-524™ derived only from the New Zealand green-lipped mussel, with 30 healthy fatty acids including DHA and EPA. Sold in other parts of the world under its sister brand name Lyprinol, Omega XL is manufactured exclusively by Great HealthWorks Inc., and is the most widely available omega-3 fish oil supplement containing the potent PCSO-524™ marine lipid extract. To find more information about Omega XL and PCSO-524™ visit http://www.OmegaXL.com

Source: Archives of Medical Research, 2012 Jul 23.
Omega-3 Polyunsaturated Fatty Acids and Rheumatoid Arthritis Treatment: A Meta-analysis.
Lee YH, Bae SC, Song GG.
Department of Internal Medicine, Division of Rheumatology, Korea University College of Medicine, Seoul, Korea.
http://www.ncbi.nlm.nih.gov/pubmed/22835600

About Great HealthWorks, Inc.
Great HealthWorks, founded in 2003, is a global manufacturer and distributor of one-of-a-kind, natural products. Great HealthWorks, the makers of Omega XL®, an all-natural, highly purified marine lipid extract from the green-lipped mussel (Perna Canaliculus) known as PCSO-524™. This patented marine lipid complex comes exclusively from the pristine waters of the Marlborough Sounds in New Zealand, and contains 30 healthy fatty acids. Great HealthWorks corporate headquarters and distribution center are in Hollywood, Florida. To find out more about Great HealthWorks, visit http://www.GreatHealthWorks.com. And for more information about the benefits of Omega XL, visit http://www.OmegaXL.com. Join the conversation: http://www.facebook.com/myomegaxl


Contact